| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |